FOI 7115 - Biologic drugs in Gastroenterology
Date: 18 February 2022 to 18 February 2025
Could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department for any medical condition, and if possible, for Ulcerative Colitis, with the following biologic drugs:
|
Treatments |
Total Gastroenterology Patients |
Ulcerative Colitis Patients |
|
Adalimumab - Humira |
|
|
|
Adalimumab Biosimilar |
|
|
|
Filgotinib |
|
|
|
Golimumab |
|
|
|
Infliximab - Remicade |
|
|
|
Infliximab Biosimilar |
|
|
|
Ozanimod |
|
|
|
Tofacitinib |
|
|
|
Ustekinumab |
|
|
|
Vedolizumab |
|
|
- Request ID:7115
- Category:Clinical - Drugs
- Response:
February 2022
Thank you for your recent request under the Freedom of Information Act 2000.
The information you have requested is as follows:
Could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department for any medical condition, and if possible, for Ulcerative Colitis, with the following biologic drugs:
Treatments
Total Gastroenterology Patients
Ulcerative Colitis Patients
Adalimumab - Humira
Adalimumab Biosimilar
Filgotinib
Golimumab
Infliximab - Remicade
Infliximab Biosimilar
Ozanimod
Tofacitinib
Ustekinumab
Vedolizumab
Please see below data held for Gastroenterology patients. The Trust can provide the number of patients, but unable to provide the indication that the drug was prescribed for as this is not recorded against pharmacy data. Therefore we are unable to advise how many patients were issued drugs for ulcerative colitis. If the drug is not listed, it is because it has not been issued.
Drug Name, Strength and Form
Number of Patients
HOMECARE ADALIMUMAB (AMGEVITA) 40 mg in 0.8ml Pre-filled Pen
<5
HOMECARE ADALIMUMAB (HUMIRA) 40 mg in 0.4ml Pre-filled Pen
12
HOMECARE ADALIMUMAB (IMRALDI) 40 mg in 0.8ml Pre-filled Pen
105
HOMECARE GOLIMUMAB (SIMPONI) 100 mg Pre-filled Pen
<5
HOMECARE GOLIMUMAB (SIMPONI) 50 mg Pre-filled Pen
<5
HOMECARE INFLIXIMAB (REMSIMA) 120 mg Pre-filled Pen
7
HOMECARE TOFACITINIB (XELJANZ) 5 mg Tablets
<5
HOMECARE USTEKINUMAB (STELARA) 90 mg in 1ml Pre-filled Syringe
12
HOMECARE VEDOLIZUMAB (ENTYVIO SC) Pre-filled Pen 108 mg in 0.68ml for SUBCUTANEOUS Injection
10
inFLIXimab (INFLECTRA) 100 mg Intravenous Infusion
<5
inFLIXimab (REMICADE) 100 mg Intravenous Infusion
<5
inFLIXimab (REMSIMA) 100 mg Intravenous Infusion
67
USTEKINUMAB 130 mg Solution for Infusion Vial
5
VEDOLIZUMAB 300 mg Powder for Solution Infusion
34
